Consequently, PGRN has been established as a diagnostic biomarker in several neoplastic diseases, and studies have demonstrated correlations between serum PGRN levels and cancer prognosis, as well as recurrence in certain cancers [9,10,11,12,13]. Here, GRN is linked to neoplasm.